Cross-presentation of lactoferrin encapsulated into chitosan-based nanoparticles
Nanobiomedicine · 2016
DOI: 10.1177/1849543516667355 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nanobiomedicine, 2016. Verfasst von Tatiana Lyalina und 3 weiteren Autor:innen. Beteiligte Einrichtung: Enzyme engineering laboratory, Institute of Bioengineering, Research Center of Biotechnology of the Russian Academy of Sciences, Moscow, Russian Fede…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Induction of CD8 + cytotoxic T-cell response is essential for the protection from intracellular pathogens. It requires major histocompatibility complex class I processing of newly synthesized proteins transported from the cytosolic pathway. Presentation of mature soluble proteins occurs via a cross-presentation (CP) pathway that is much less efficient in the activation of cytotoxic response. Encapsulation of proteins into polymeric nanoparticles (NPs) can modulate the efficacy of antigen CP. In this article, a model antigen lactoferrin (L) was encapsulated into polysaccharide NPs with different physicochemical properties (size, charge, and hydrophobicity) and used as an immunogen. CD8 + or CD4 + associated IgG2a or IgG1 subclasses of L-specific antibodies, respectively, served as a measure of CD8 + versus CD4 + T-cell activation. Among five types of NPs produced, only succinylchitosan–galactomannan (LSG) and succinylchitosan–PEG-chitosan (LSPC) NPs induced a significant IgG2a response. IgG1 production was comparable in all but hydrophobic succinyl-dodecyl-chitosan (LSD) NPs, where it was only marginal. Confocal studies demonstrated that galactomannan-equipped LSG-NPs induced vacuolar type of CP, while positively charged LSPC-NPs were transported mostly via the cytosolic CP pathway.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Enzyme engineering laboratory, Institute of Bioengineering, Research Center of Biotechnology of the Russian Academy of Sciences, Moscow, Russian Federation.
- Immunology Department, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russian Federation.
Zitieren
APA
Lyalina, T., Zubareva, A., Varlamov, V., & Svirshchevskaya, E. (2016). Cross-presentation of lactoferrin encapsulated into chitosan-based nanoparticles. Nanobiomedicine. https://doi.org/10.1177/1849543516667355
Vancouver
Lyalina T, Zubareva A, Varlamov V, Svirshchevskaya E. Cross-presentation of lactoferrin encapsulated into chitosan-based nanoparticles. Nanobiomedicine. 2016. doi:10.1177/1849543516667355
BibTeX
@article{Lyalina2016,
author = {Lyalina, Tatiana and Zubareva, Anastasia and Varlamov, Valery and Svirshchevskaya, Elena},
title = {Cross-presentation of lactoferrin encapsulated into chitosan-based nanoparticles},
journal = {Nanobiomedicine},
year = {2016},
doi = {10.1177/1849543516667355}
}
EUVIMED